Rehmann Capital Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $884K | Buy |
1,683
+231
| +16% | +$121K | 0.05% | 237 |
|
|
2025
Q1 | $921K | Buy |
1,452
+770
| +113% | +$488K | 0.06% | 235 |
|
|
2024
Q4 | $487K | Buy |
682
+144
| +27% | +$103K | 0.03% | 354 |
|
|
2024
Q3 | $572K | Sell |
538
-93
| -15% | -$98.9K | 0.04% | 317 |
|
|
2024
Q2 | $663K | Buy |
631
+30
| +5% | +$31.5K | 0.05% | 267 |
|
|
2024
Q1 | $578K | Buy |
601
+76
| +14% | +$73.1K | 0.04% | 290 |
|
|
2023
Q4 | $461K | Buy |
525
+42
| +9% | +$36.9K | 0.04% | 329 |
|
|
2023
Q3 | $397K | Buy |
483
+20
| +4% | +$16.5K | 0.04% | 339 |
|
|
2023
Q2 | $333K | Buy |
463
+13
| +3% | +$9.34K | 0.03% | 398 |
|
|
2023
Q1 | $370K | Buy |
450
+50
| +13% | +$41.1K | 0.03% | 369 |
|
|
2022
Q4 | $289K | Sell |
400
-63
| -14% | -$45.5K | 0.03% | 426 |
|
|
2022
Q3 | $319K | Buy |
463
+8
| +2% | +$5.51K | 0.04% | 362 |
|
|
2022
Q2 | $269K | Sell |
455
-541
| -54% | -$320K | 0.03% | 398 |
|
|
2022
Q1 | $696K | Buy |
996
+49
| +5% | +$34.2K | 0.07% | 257 |
|
|
2021
Q4 | $601K | Buy |
947
+44
| +5% | +$27.9K | 0.06% | 280 |
|
|
2021
Q3 | $546K | Buy |
903
+31
| +4% | +$18.8K | 0.05% | 303 |
|
|
2021
Q2 | $490K | Sell |
872
-124
| -12% | -$69.7K | 0.05% | 313 |
|
|
2021
Q1 | $472K | Buy |
996
+81
| +9% | +$38.4K | 0.05% | 298 |
|
|
2020
Q4 | $442K | Buy |
+915
| New | +$442K | 0.05% | 289 |
|
|
2019
Q3 | $1.94K | Sell |
7
-5
| -42% | -$1.39K | ﹤0.01% | 1417 |
|
|
2019
Q2 | $3.76K | Sell |
12
-198
| -94% | -$62K | ﹤0.01% | 1624 |
|
|
2019
Q1 | $86.2K | Buy |
210
+50
| +31% | +$20.5K | 0.01% | 634 |
|
|
2018
Q4 | $59.8K | Buy |
160
+88
| +122% | +$32.9K | 0.01% | 538 |
|
|
2018
Q3 | $29.1K | Buy |
72
+68
| +1,700% | +$27.5K | ﹤0.01% | 999 |
|
|
2018
Q2 | $1.38K | Sell |
4
-44
| -92% | -$15.2K | ﹤0.01% | 1896 |
|
|
2018
Q1 | $17K | Buy |
+48
| New | +$17K | ﹤0.01% | 1134 |
|